Schedule 13G ownership disclosure

BIOCRYST PHARMACEUTICALS INC

Security class unavailable · CUSIP: 09058V103

Event date: 2017-02-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,707,857
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-012932
Form type
SC 13G
Filer
BIOCRYST PHARMACEUTICALS INC
CIK
CIK 882796
Filed
Mar 06, 2017
Reporting period
Feb 23, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub